Cited by 2,803Cancer-related Molecular PathwaysDNA Repair MechanismsMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., Vogelstein, B.·1998·Science

DOI 10.1126/science.282.5393.1497

Open this paper in CoChat — free account

Abstract

After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.

Integrity signals

Registry

Crossref · 10.1126/science.282.5393.1497

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Cell Cycle Control and Cancer
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citation
Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation

Flagged first, then by citations

Show all 50 references

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 13

Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
Powell S. N., et al., Cancer Res. 55, 1643 (1995);
Fan S., et al., Cancer Res. 55, 1649 (1995);
Russell K. J., et al., ibid. 55, 1639 (1995).
Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
Michieli P., et al., Cancer Res. 54, 3391 (1994);
Paules R. S., et al., Cancer Res 55, 1763 (1995);
Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);

Sorted by citations

Items 101–200 of 1,018

Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
Chang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 387
PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4 Cdt2 ubiquitin ligase complexPreprint
Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., & Dutta, A. (2008) · Genes & Development · doi:10.1101/gad.1676108 · Cited by 363
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
Duensing, S. M., & Münger, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 362
Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress
Hori, Y. S., Kuno, A., Hosoda, R., & Horio, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073875 · Cited by 366
Securin Is Required for Chromosomal Stability in Human Cells
Jallepalli, P. V., Waizenegger, I. C., Bunz, F., Langer, S., Speicher, M. R., Peters, J., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00340-3 · Cited by 366
Self-citation
Opposing Effects of Ras on p53
Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., & McCormick, F. (2000) · Cell · doi:10.1016/s0092-8674(00)00123-9 · Cited by 357
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 359
Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth
Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., & Inoue, S. (2002) · Nature · doi:10.1038/nature00826 · Cited by 357
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
Bacus, S. S., Gudkov, A. V., Lowe, M., Lyass, L., Yung, Y., Komarov, A. P., Keyomarsi, K., Yarden, Y., & Seger, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204062 · Cited by 356
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer
Marcel, V., Ghayad, S. E., Belin, S., Thérizols, G., Morel, A., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 394
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.015 · Cited by 346
Cell-cycle dysregulation and anticancer therapy
Stewart, Z. A., Westfall, M. D., & Pietenpol, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00026-9 · Cited by 343
p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
Hirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 333
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Aarts, M., Sharpe, R., García-Murillas, I., Gevensleben, H., Hurd, M. S., Shumway, S. D., Toniatti, C., Ashworth, A., & Turner, N. C. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0320 · Cited by 327
The p53 tumor suppressor participates in multiple cell cycle checkpoints
Giono, L. E., & Manfredi, J. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20689 · Cited by 342
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Metzemaekers, M., Vanheule, V., Janssens, R., Struyf, S., & Proost, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01970 · Cited by 335
Ki-67 gene expression
Uxa, S., Castillo-Binder, P., Kohler, R., Stangner, K., Müller, G. A., & Engeland, K. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00823-x · Cited by 315
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB
Ravi, R. K., Bedi, G. C., Engstrom, L., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., & Bedi, A. (2001) · Nature Cell Biology · doi:10.1038/35070096 · Cited by 316
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Hu, W., Chan, C. S., Wu, R., Zhang, C., Sun, Y., Song, J. S., Tang, L. H., Levine, A. J., & Feng, Z. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.027 · Cited by 321
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α
Koh, M. Y., Spivak-Kroizman, T., Venturini, S., Welsh, S., Williams, R. R., Kirkpatrick, D. L., & Powis, G. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0463 · Cited by 309
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 309
Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinasesPreprint
Lefort, K., Mandinova, A., Ostano, P., Kolev, V. N., Calpini, V., Kolfschoten, I., Devgan, V., Lieb, J., Raffoul, W., Hohl, D., et al. (2007) · Genes & Development · doi:10.1101/gad.1484707 · Cited by 313
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo
Kaeser, M. D., & Iggo, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012283399 · Cited by 302
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53
Rivas, C., Thlick, A.-E., Parravicini, C., Moore, P. S., & Chang, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.429-438.2001 · Cited by 295
Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3
Sidi, S., Sanda, T., Kennedy, R. D., Hagen, A. T., Jette, C. A., Hoffmans, R., Pascual, J., Imamura, S., Kishi, S., Amatruda, J. F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.037 · Cited by 304
Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation
Feng, J., Tamaskovic, R., Yang, Z., Brazil, D. P., Merlo, A., Hess, D., & Hemmings, B. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404936200 · Cited by 294
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
Lin, J. J., Milhollen, M. A., Smith, P. G., Narayanan, U., & Dutta, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2062 · Cited by 297
CENTROSOMES IN CELLULAR REGULATION
Doxsey, S., McCollum, D., & Theurkauf, W. E. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120418 · Cited by 293
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
Sur, S., Pagliarini, R. A., Bunz, F., Rago, C., Diaz, L. A., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813333106 · Cited by 293
Self-citation
NQO1 stabilizes p53 through a distinct pathway
Asher, G., Lotem, J., Kama, R., Sachs, L., & Shaul, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052706799 · Cited by 291
P21-dependent G1arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
Sandor, V., Senderowicz, A. M., Mertins, S. D., Sackett, D. L., Sausville, E. A., Blagosklonny, M. V., & Bates, S. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1327 · Cited by 290
The same, only different – DNA damage checkpoints and their reversal throughout the cell cycle
Shaltiël, I. A., Krenning, L., Bruinsma, W., & Medema, R. H. (2015) · Journal of Cell Science · doi:10.1242/jcs.163766 · Cited by 310
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., Rendo, V., Abdusamad, M., Lam, D., Davison, D., Pal, S., Currimjee, N., Hess, J., Pantel, S., Nag, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0623-4 · Cited by 285
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ
Achanta, G., Sasaki, R., Li, F., Carew, J. S., Lu, W., Pelicano, H., Keating, M. J., & Huang, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600819 · Cited by 285
Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203176 · Cited by 283
Negative regulation of the tumor suppressor p53 gene by microRNAs
Kumar, M., Lu, Z., Takwi, A. A., Chen, W., Callander, N. S., Ramos, K. S., Young, K. H., & Li, Y. (2010) · Oncogene · doi:10.1038/onc.2010.457 · Cited by 287
A Vital Role for Ape1/Ref1 Protein in Repairing Spontaneous DNA Damage in Human Cells
Fung, H., & Demple, B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.029 · Cited by 285
Caenorhabditis elegans HUS-1 Is a DNA Damage Checkpoint Protein Required for Genome Stability and EGL-1-Mediated Apoptosis
Hofmann, E. R., Milstein, S., Boulton, S. J., Ye, M., Hofmann, J., Stergiou, L., Gartner, A., Vidal, M., & Hengartner, M. O. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01262-9 · Cited by 280
Control of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 282
Regulation of cell death by the Abl tyrosine kinase
Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 279
Apoptosis and non-apoptotic deaths in cancer development and treatment response
de Bruin, E. C., & Medema, J. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.001 · Cited by 285
Genetic Disruption of Cytosine DNA Methyltransferase Enzymes Induces Chromosomal Instability in Human Cancer Cells
Karpf, A. R., & Matsui, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1961 · Cited by 276
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 284
Role of Reactive Oxygen Species and p53 in Chromium(VI)-induced Apoptosis
Ye, J., Wang, S., Leonard, S. S., Sun, Y. J., Butterworth, L. F., Antonini, J., Ding, M., Rojanasakul, Y., Vallyathan, V., Castranova, V., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34974 · Cited by 276
Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells
Yamaguchi‐Iwai, Y., Sonoda, E., Sasaki, M. S., Morrison, C., Haraguchi, T., Hiraoka, Y., Yamashita, Y. M., Yagi, T., Takata, M., Price, C., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6619 · Cited by 277
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
Arango, D., Wilson, A. J., Shi, Q., Corner, G. A., Aranes, M., Nicholas, C., LESSER, M. L., Mariadason, J. M., & Augenlicht, L. H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602215 · Cited by 273
Functional characterization of the TERRA transcriptome at damaged telomeres
Porro, A., Feuerhahn, S., Delafontaine, J., Riethman, H. C., Rougemont, J., & Lingner, J. (2014) · Nature Communications · doi:10.1038/ncomms6379 · Cited by 289
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
Ma, C. X., Janetka, J. W., & Piwnica-Worms, H. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.009 · Cited by 276
Pituitary Tumor-Transforming Gene: Physiology and Implications for Tumorigenesis
Vlotides, G., Eigler, T., & Melmed, S. K. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0042 · Cited by 270
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X. M., McChesney, P. A., Jackson‐Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 275
Prognostic Values of microRNAs in Colorectal Cancer.
Xi, Y., Formentini, A., Chien, M., Weir, D. B., Russo, J. J., Ju, J., Kornmann, M., & Ju, J. (2006) · PubMed Central · Cited by 268
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Avissar-Whiting, M., Christensen, B. C., Kelsey, K. T., & Marsit, C. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3131 · Cited by 275
Ubiquitin- and ATP-Independent Proteolytic Turnover of p21 by the REGγ-Proteasome Pathway
Li, X., Amazit, L., Long, W., Lonard, D. M., Monaco, J. J., & O’Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.028 · Cited by 267
Cytokinesis defects and cancer
Lens, S. M. A., & Medema, R. H. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0084-6 · Cited by 276
Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage
Yoon, H. S., Chen, X., & Yang, V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211027200 · Cited by 265
A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents.
Sánchez‐Prieto, R., Rojas, J. M., Taya, Y., & Gutkind, J. S. (2000) · PubMed · Cited by 264
PintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2
Marín-Béjar, O., Marchese, F. P., Athie, A., Sánchez, Y., González, J., Segura, V., Huang, L., Moreno, I., Navarro, A., Monzó, M., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-9-r104 · Cited by 269
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional programPreprint
Gomes, N. P., Bjerke, G. A., Llorente, B., Szostek, S. A., Emerson, B. M., & Espinosa, J. M. (2006) · Genes & Development · doi:10.1101/gad.1398206 · Cited by 264
Loss of Geminin induces rereplication in the presence of functional p53
Melixetian, M. B., Ballabeni, A., Masiero, L., Gasparini, P., Zamponi, R., Bártek, J., Lukas, J., & Helin, K. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403106 · Cited by 271
What the nucleolus says to a tumour pathologist
Derenzini, M., Montanaro, L., & Treré, D. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03168.x · Cited by 271
Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions
Cesare, A. J., Kaul, Z., Cohen, S. B., Napier, C. E., Pickett, H. A., Neumann, A. A., & Reddel, R. R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1725 · Cited by 263
Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin
Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., & Wyche, J. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112401200 · Cited by 262
Self-citation
Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2.
Hsieh, T. C., Juan, G., Darżynkiewicz, Z., & WU, J. M. (1999) · PubMed · Cited by 262
Cooperative effects of genes controlling the G2/M checkpointPreprint
Chan, T. A.-T., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 261
Self-citation
New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy
Mirzayans, R., Andrais, B., Scott, A., & Murray, D. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/170325 · Cited by 257
Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications
Allen, D. A., Yaqoob, M. M., & Harwood, S. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.06.007 · Cited by 256
Human Cyclin a Is Required for Mitosis until Mid Prophase
Furuno, N., den Elzen, N. R., & Pines, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.295 · Cited by 254
Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host
Buti, L., Spooner, E., Van der Veen, A. G., Rappuoli, R., Covacci, A., & Ploegh, H. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106200108 · Cited by 253
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
Zhang, X., Fryknäs, M., Hernlund, E., Fayad, W., Milito, A. D., Olofsson, M. H., Gogvadze, V. G., Dang, L. H., Påhlman, S., Kunz‐Schughart, L. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms4295 · Cited by 263
14-3-3 Proteins—a focus on cancer and human disease
Wilker, E., & Yaffe, M. B. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.015 · Cited by 251
MYC Oncogene Contributions to Release of Cell Cycle Brakes
García-Gutiérrez, L., Delgado, M. D., & León, J. (2019) · Genes · doi:10.3390/genes10030244 · Cited by 264
Foxo3 Is Essential for the Regulation of Ataxia Telangiectasia Mutated and Oxidative Stress-mediated Homeostasis of Hematopoietic Stem Cells
Yalcin, S., Zhang, X., Luciano, J. P., Mungamuri, S. K., Marinkovic, D., Vercherat, C., Sarkar, A., Grisotto, M., Taneja, R., & Ghaffari, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800517200 · Cited by 247
Transforming Growth Factor β-1 Stimulates Profibrotic Epithelial Signaling to Activate Pericyte-Myofibroblast Transition in Obstructive Kidney Fibrosis
Wu, C.-F., Chiang, W., Lai, C., Chang, F., Chen, Y., Chou, Y., Wu, T.-H., Linn, G. R., Ling, H., Wu, K., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.009 · Cited by 247
Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3βPreprint
Qu, L.-K., Huang, S. H., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., & Koromilas, A. E. (2004) · Genes & Development · doi:10.1101/gad.1165804 · Cited by 253
Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity
Hiller, B., Achleitner, M., Glage, S., Naumann, R., Behrendt, R., & Roers, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120876 · Cited by 245
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A., Takahashi, S. I., Kato, S., Suzuki, T., Ishioka, C., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0174 · Cited by 244
Pomegranate Extracts Potently Suppress Proliferation, Xenograft Growth, and Invasion of Human Prostate Cancer Cells
Albrecht, M., Jiang, W. G., Kumi-Diaka, J. K., Lansky, E. S., Gommersall, L. M., Patel, A. N., Mansel, R. E., Neéman, I., Geldof, A. A., & Campbell, M. J. (2004) · Journal of Medicinal Food · doi:10.1089/jmf.2004.7.274 · Cited by 242
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion
Schulz‐Heddergott, R., Stark, N., Edmunds, S. J., Li, J., Conradi, L., Bohnenberger, H., Ceteci, F., Greten, F. R., Dobbelstein, M., & Moll, U. M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.004 · Cited by 243
Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology
Dutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 242
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
Kim, B. M., Hong, Y., Lee, S., Liu, P., Lim, J. Y., Lee, Y. C., Lee, T., Chang, K. T., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 243
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A. J., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 238
Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response
Wei, X., Xu, H., & Kufe, D. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.008 · Cited by 234
G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells
Blajeski, A. L., Phan, V. A., Kottke, T. J., & Kaufmann, S. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13275 · Cited by 200
A ribonucleotide reductase gene is a transcriptional target of p53 and p73
Nakano, K., Bálint, É., Ashcroft, M. A., & Vousden, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203774 · Cited by 231
G1 tetraploidy checkpoint and the suppression of tumorigenesis
Margolis, R. L., Lohez, O. D., & Andreassen, P. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10411 · Cited by 238
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
Hirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 230
Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan
Boyer, J. D., McLean, E. G., Aroori, S., Wilson, P. M., McCulla, A., Carey, P. D., Longley, D. B., & Johnston, P. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0362 · Cited by 236
MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
Xia, P., Zhang, H., Xu, K., Jiang, X. W., Gao, M., Wang, G., Liu, Y., Yao, Y., Chen, X., Ma, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03973-5 · Cited by 230
p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage
Rubbi, C. P., & Milner, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg082 · Cited by 234
Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers, M., Wagner, M. W., Hwang, H. S., Kinsella, T. J., & Boothman, D. A. (2001) · PubMed · Cited by 228
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
Giannakakou, P., Robey, R. W., Fojo, T., & Blagosklonny, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204487 · Cited by 228
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
Bitar, S. A., & Gali‐Muhtasib, H. U. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 231
Rereplication by Depletion of Geminin Is Seen Regardless of p53 Status and Activates a G2/M Checkpoint
Zhu, W., Chen, Y., & Dutta, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7140-7150.2004 · Cited by 225
From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.
Padhyé, S., Banerjee, S., Ahmad, A., Mohammad, R. M., & Sarkar, F. H. (2008) · PubMed · Cited by 222
p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005437200 · Cited by 221

Authors: Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
Affiliations: Howard Hughes Medical Institute (US)
F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
Corresponding author: Vogelstein, B.
ORCID: Bunz, F.
Dutriaux, A.
Waldman, T.
Zhou, S.
Brown, J. P.
Sedivy, J. M.
Kinzler, K. W.
Vogelstein, B.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1998-11-20
Volume: 282
Issue: 5393
Pages: 1497-1501
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.282.5393.1497
OpenAlex: W2080125477
Cited by: 2,803
References: 50
Citations by year: 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
FWCI: 41.60
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords: p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
MeSH terms: Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks